Screener
AngioDynamics ANGO Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: AngioDynamics’s 10-Q, filed October 8, 2026.
- Filed
- Oct 8, 2026, 12:56 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001628280-26-065423
| Line item | Three Months Ended / Aug 31, 2026 | Three Months Ended / Aug 31, 2025 |
|---|---|---|
| Net sales | $80,915 | $75,711 |
| Cost of sales (exclusive of intangible amortization) | 32,875 | 33,854 |
| Gross margin | 48,040 | 41,857 |
| Operating expenses: | ||
| Research and development | 7,979 | 6,417 |
| Sales and marketing | 29,986 | 28,130 |
| General and administrative | 12,467 | 12,555 |
| Amortization of intangibles | 2,729 | 2,653 |
Item 1. Financial Statements.
FAQ
- What is AngioDynamics's total revenue?
- AngioDynamics (ANGO) reported total revenue of $80.92M in Q2 2026.
- How has AngioDynamics's total revenue changed year-over-year?
- AngioDynamics's total revenue increased by 6.9% year-over-year, from $75.71M to $80.92M.
- What is the long-term trend for AngioDynamics's total revenue?
- Over 4 years (2022 to 2026), AngioDynamics's total revenue has grown at a 0.3% compound annual growth rate (CAGR), from $316.22M to $320.17M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about AngioDynamics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude